Investigation of Novel Variants in Familial Multiple Sclerosis Through Family-based Association Tests and Segregation Analyses
Aksel Siva1, Alper Bulbul2, Elif Everest3, Melih Tutuncu1, Ugur Uygunoglu1, Sabahattin Saip1, Caner Feyzi Demirkaya4, Cavit Boz5, Fatih Yetkin6, Husnu Efendi7, Sena Destan Bunul8, Taskin Duman9, Mehmet Tecellioglu10, Murat Terzi11, Sedat Sen12, Rana Karabudak13, Asli Tuncer14, Cihat Uzunkopru15, Omer Turan16, Serkan Demir17, Tuncay Gunduz18, Ufuk Aluclu19, Haluk Gumus20, Umut Voyvoda2, Osman Sezerman2, Eda Turanli2
1Istanbul University-Cerrahpasa, 2Acibadem University, 3NIAID, NIH, 4Firat University, 5Karadeniz Technical University, 6Erciyes University, 7Gen Pharmacenticals, 8Kocaeli University, 9Flukara Numune Hospital, 10Inonu University, 11Onkoduz Mayis University, 12Ondokuz Mayis University, 13Academic Neurologist, 14Hacettepe University, 15Katip Celebi University, 16Uludag University, 17Dr Ilhan Varank Hospital, 18Istanbul University, 19Dicle University, 20Selcuk University
Objective:

Our study aimed to discover novel, rare variants associated with the risk of familial multiple sclerosis (MS) in a cohort of 45 multi-affected families.

Background:

Multiply affected families, characterized by a high degree of consanguinity, have offered unique advantages in search of novel variants. 

Design/Methods:
Three distinct association tools, namely the familial Functional Haplotype Association Test (famFHAT), Exomiser, and the Protein Variation Analysis and Annotation System Tool (pVAAST), were employed to analyze exome sequencing data from 101 patients with MS and 53 unaffected relatives.
Results:

Among these tools, famFHAT emerged as the most robust and reliable tool, revealing significant findings at a stringent p-value threshold of <0.001. Notably, two genes, UMODL1 and ATXN3, drew our attention due to their roles in MS phenotypes, which were supported by functional evidence, mouse models, and expression patterns in the literature. UMODL1 is involved in extracellular matrix and neutrophil migration, and ATXN3 is associated with the innate immune system pathway. To further investigate the highlighted genes, we conducted segregation analysis in 45 families using the full-likelihood Bayes factor (FLB) algorithm, following ACMG guidelines and utilizing penetrance values of 0.001, 0.6, and 0.6. Specifically, there were seven variants with a minor allele frequency cutoff of 0.02 in UMODL1, all with protein-altering consequences and absent in non-MS family members. These UMODL1 exonic variations showed segregation across nine families. Notably, the rs114358105 stop gain and the rs150611312 missense variants were observed in diverse familial patterns and among siblings, respectively.

Conclusions:

Our study successfully identified novel, rare variants associated with familial MS, with famFHAT as the most reliable tool in our study. These findings highlighted the significance of genes, such as UMODL1 and ATXN3, in MS pathogenesis, providing insights into potential pathogenic implications in familial MS cohorts.

10.1212/WNL.0000000000206230